Tumor treating fields: a comprehensive overview of the underlying molecular mechanism
- PMID: 34883030
- DOI: 10.1080/14737159.2022.2017283
Tumor treating fields: a comprehensive overview of the underlying molecular mechanism
Abstract
Introduction: As a novel treatment modality, tumor treating fields (TTFields) exert low-intensity, medium-frequency electric fields on tumor cells. TTFields' effectiveness and safety have been demonstrated clinically and in the real world for treating glioblastoma, the most common and aggressive primary central nervous system tumor. TTFields therapy has also been approved for the management of malignant mesothelioma, and clinical trials are ongoing for NSCLC, gastric cancer, pancreatic cancer, and other solid tumors.
Areas covered: This article comprehensively reviews the currently described evidence of TTFields' mechanism of action. TTFields' most evident therapeutic effect is to induce cell death by disrupting mitosis. Moreover, evidence suggests at additional mechanistic complexity, such as delayed DNA repair and heightened DNA replication stress, reversible increase in cell membrane and blood-brain barrier permeability, induction of immune response, and so on.
Expert opinion: TTFields therapy has been arising as the fourth anti-tumor treatment besides surgery, radiotherapy, and antineoplastic agents in recent years. However, the precise molecular mechanisms underlying the effects of TTFields are not fully understood and some concepts remain controversial. An in-depth understanding of TTFields' effects on tumor cell and tumor microenvironment would be crucial for informing research aimed at further optimizing TTFields' efficacy and developing new combination therapies for clinical applications.
Keywords: Antitumor activity; combination therapy; glioblastoma (GBM); molecular mechanism; tumor treating fields (TTfields).
Similar articles
-
Tumor treating fields: narrative review of a promising treatment modality for cancer.Chin Clin Oncol. 2023 Dec;12(6):64. doi: 10.21037/cco-23-82. Epub 2023 Nov 2. Chin Clin Oncol. 2023. PMID: 37953242 Review.
-
An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications.Int J Radiat Biol. 2021;97(8):1044-1054. doi: 10.1080/09553002.2020.1837984. Epub 2020 Oct 29. Int J Radiat Biol. 2021. PMID: 33086019 Review.
-
A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights.Radiol Oncol. 2023 Sep 4;57(3):279-291. doi: 10.2478/raon-2023-0044. eCollection 2023 Sep 1. Radiol Oncol. 2023. PMID: 37665740 Free PMC article. Review.
-
Therapeutic potential of tumor treating fields for malignant brain tumors.Cancer Rep (Hoboken). 2023 May;6(5):e1813. doi: 10.1002/cnr2.1813. Epub 2023 Mar 29. Cancer Rep (Hoboken). 2023. PMID: 36987739 Free PMC article. Review.
-
T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields.J Immunol. 2021 Jul 15;207(2):709-719. doi: 10.4049/jimmunol.2100100. Epub 2021 Jul 2. J Immunol. 2021. PMID: 34215656
Cited by
-
Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis.Front Oncol. 2022 Nov 10;12:1055366. doi: 10.3389/fonc.2022.1055366. eCollection 2022. Front Oncol. 2022. PMID: 36439464 Free PMC article. Review.
-
Advancements and current trends in tumor treating fields: a scientometric analysis.Int J Surg. 2024 May 1;110(5):2978-2991. doi: 10.1097/JS9.0000000000001151. Int J Surg. 2024. PMID: 38349201 Free PMC article.
-
Research Progress on the Mechanism of Anti-Tumor Immune Response Induced by TTFields.Cancers (Basel). 2023 Nov 29;15(23):5642. doi: 10.3390/cancers15235642. Cancers (Basel). 2023. PMID: 38067345 Free PMC article. Review.
-
Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence.Medicine (Baltimore). 2023 Dec 1;102(48):e36421. doi: 10.1097/MD.0000000000036421. Medicine (Baltimore). 2023. PMID: 38050252 Free PMC article. Review.
-
Whole-transcriptome sequencing with ceRNA regulation network construction and verification in glioblastoma.Am J Transl Res. 2023 Jun 15;15(6):4291-4313. eCollection 2023. Am J Transl Res. 2023. PMID: 37434823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials